Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Dabigatran

  • A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab

    The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about...
  • New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab

    Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved...
  • Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More

    Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum...

A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - W. Richard Bukata, MD - 0 Comment

The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…

Read More

New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab

February 5, 2019 - Mary Choy, PharmD, BCGP, FASHP - 1 Comment

Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…

Read More

Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More

November 12, 2017 - Ryan Patrick Radecki, MD, MS - 1 Comment

Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum…

Read More

Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients

August 1, 2017 - Gene Emery (Reuters Health) - 0 Comment

The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…

Read More

New Developments in Direct Oral Anticoagulant Safety and Indications

September 14, 2015 - Ryan Patrick Radecki, MD, MS - 0 Comment

Much has changed in the realm of oral anticoagulation over the past few years. Beginning with the…

Read More
Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603